Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- General Oncology
- Carcinomas
- Lymphoma
- Prostate Cancer
- Chemotherapy and Radiotherapy
- Pancreatic Cancer
- Haemato-Oncology
- Urological Cancers
Welcome
Clinics in Oncology™ (Impact Factor: 2.709*) and (ISSN 2474-1663) is an interdisciplinary and borderless journal serves as the most reputable and authoritative platform for distributing key clinical oncology research to its readers, associated with Breast Cancer, Gastrointestinal Cancer, Hematologic Malignancies, Molecular Oncology, Thoracic Cancer, Genitourinary Cancer, Head and neck Cancer, Cervical Cancer, Bladder Cancer, Colon Cancer, Colorectal Cancer, Lung Cancer, Pediatric Cancer, Ovarian Cancer, Prostate Cancer, Surgical Oncology, Pediatric Oncology, Neuro-Oncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readers include active clinical oncologists in practice, researchers, students, trainees, and allied health professionals worldwide.
Clinics in Oncology™ (Impact Factor: 2.709*) encircles a wide range of informative and advanced articles that contribute significantly to the field of oncology. The journal's scope covers various aspects of oncology research, including basic science, translational research, clinical studies, and reviews.
NLM ID
Recently Published Articles
Neutrophil–Lymphocyte Ratio Predicts Overall Survival in Elderly Patients with Unresectable or Recurrent Gastric Cancer
Yamauchi Y, Sofuni A, Suzuki Y, Iwasaki K, Fukuzawa M, Nagakawa Y and Itoi T
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2023;8(1):2027. DOI: 10.25107/2474-1663.2027
Differential Expression of PP2A and Set in Hepatocellular Carcinoma: Antitumoral Effect of an Interfering Peptide Blocking the Interaction
Rachid Boudjelloul, Angelita Rebollo, Severine Loisel, Frederic Charlotte, Jean Francois Franetich and Eric Savier
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2023;8(1):2028. DOI: 10.25107/2474-1663.2028
Lack of Reactivation of Latent Tuberculosis Despite PD-1 Immunotherapy and Chemotherapy: A Case Report and Systematic Review
Yang X, Xian XH, Zhu Q and Wang K
Abstract PDF Full Text Case Report | Open Access
Citation: Clin Oncol. 2023;8(1):2026. DOI: 10.25107/2474-1663.2026
Serum Lipid Profile and Breast Carcinogenesis among Qatari Young Women
Al Ghatam G, El Mistiri M and Belbraouet S
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2023;8(1):2025. DOI: 10.25107/2474-1663.2025
Inflammatory Pathways from Benign Prostatic Hyperplasia to Prostate Cancer - in Search of New Therapeutic Options
Janiczek-Polewska M, Szylberg L, Antosik P, Kasperska A, Malicki J and Marszałek A
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2023;8(1):2024. DOI: 10.25107/2474-1663.2024
Identification of Differentially Expressed Genes and Signaling Pathways in Esophageal Squamous Cell Carcinoma Using Bioinformatics Analysis
Zou Z, Lu Z, Hu Y, Liang Y and Li X
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2023;8(1):2023. DOI: 10.25107/2474-1663.2023
Search Our Journal
Journal Indexed In
